423 / 1068
The Royal Marsden
Feasibility secondary endpoints
– Assess response rates by comparing the reported
mrTRG in the control and intervention arm
– Evaluate the reproducibility of mrTRG by
recruiting radiologists
– To evaluate safety by assessing acute drug toxicity
and 30 day surgical morbidity
– pCRM involvement rate in the control versus
intervention arm
– Quality of surgery in control vs intervention arms